Evidence map›Paper›PMID 37512238›Full record

ArticleMaterials (Basel, Switzerland)2023

Investigation into Brazilian Palygorskite for Its Potential Use as Pharmaceutical Excipient: Perspectives and Applications.

Lyghia Maria Araújo Meirelles, Raquel de Melo Barbosa, Rita Sanchez-Espejo, Fátima García-Villén, Luana Perioli, César Viseras, Tulio Flavio Accioly de Lima E Moura, Fernanda Nervo Raffin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lyghia Maria Araújo MeirellesDepartment of Pharmacy, Federal University of Rio Grande do Norte, R. Gen. Gustavo Cordeiro de Faria, s/n-Petrópolis, Natal 59012-570, Brazil.
Raquel de Melo BarbosaDepartment of Pharmacy, Federal University of Rio Grande do Norte, R. Gen. Gustavo Cordeiro de Faria, s/n-Petrópolis, Natal 59012-570, Brazil.ORCID 0000-0003-3798-5512
Rita Sanchez-EspejoDepartment of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Granada, Campus of Cartuja s/n, 18071 Granada, Spain.ORCID 0000-0001-6525-5723
Fátima García-VillénDepartment of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Granada, Campus of Cartuja s/n, 18071 Granada, Spain.ORCID 0000-0003-0840-650X
Luana PerioliDepartment of Pharmaceutic Science, University of Perugia, 06123 Perugia, Italy.ORCID 0000-0003-3890-3283
César ViserasDepartment of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Granada, Campus of Cartuja s/n, 18071 Granada, Spain.ORCID 0000-0002-2219-3566
Tulio Flavio Accioly de Lima E MouraDepartment of Pharmacy, Federal University of Rio Grande do Norte, R. Gen. Gustavo Cordeiro de Faria, s/n-Petrópolis, Natal 59012-570, Brazil.
Fernanda Nervo RaffinDepartment of Pharmacy, Federal University of Rio Grande do Norte, R. Gen. Gustavo Cordeiro de Faria, s/n-Petrópolis, Natal 59012-570, Brazil.ORCID 0000-0001-7623-4485

Funding

Coordination for the Improvement of Higher Education Personnel (CAPES) 88887.131333/2016-00
6 · The paper itself

Abstract

Palygorskite is an aluminum and magnesium silicate characterized by its fibrous morphology, providing it with great versatility in industrial applications, including pharmaceuticals. Although most of the reserves are in the United States, in recent years occurrences of commercially exploited deposits in Brazil have been recorded, mainly in the country's northeast region. This has motivated this study, which analyzes raw Brazilian palygorskite compared to a commercial sample (Pharmasorb

Indexed as

clay mineralexcipientspalygorskitepharmaceutical applications

Identifiers

PMID37512238
PMCPMC10381531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.